Evidence map›Paper›PMID 33451061›Full record

ArticlePharmaceutics2021

pH-Dependent Molecular Gate Mesoporous Microparticles for Biological Control of

Isabel González-Alvarez, Verónica Vivancos, Carmen Coll, Bárbara Sánchez-Dengra, Elena Aznar, Alejandro Ruiz-Picazo, Marival Bermejo, Félix Sancenón, María Auxiliadora Dea-Ayuela, Marta Gonzalez-Alvarez and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Isabel González-AlvarezDepartment of Engineering, Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Elche. San Juan Campus, 03550 San Juan, Spain.ORCID 0000-0002-1685-142X
Verónica VivancosDepartment of Engineering, Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Elche. San Juan Campus, 03550 San Juan, Spain.
Carmen CollInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València and Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain.
Bárbara Sánchez-DengraDepartment of Engineering, Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Elche. San Juan Campus, 03550 San Juan, Spain.ORCID 0000-0003-2159-4314
Elena AznarInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València and Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain.ORCID 0000-0003-0361-3876
Alejandro Ruiz-PicazoDepartment of Engineering, Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Elche. San Juan Campus, 03550 San Juan, Spain.
Marival BermejoDepartment of Engineering, Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Elche. San Juan Campus, 03550 San Juan, Spain.ORCID 0000-0001-5022-0544
Félix SancenónInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València and Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain.
María Auxiliadora Dea-AyuelaDepartamento de Farmacia, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, C/Santiago Ramón y Cajal, s/n, Alfara del Patriarca, 46115 Valencia, Spain.
Marta Gonzalez-AlvarezDepartment of Engineering, Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Elche. San Juan Campus, 03550 San Juan, Spain.
Ramón Martínez-MáñezInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València and Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain.ORCID 0000-0001-5873-9674
Universitat de Miguel Hernández d'Elx · ESUniversitat de València · ESUniversidad Cardenal Herrera CEU · ES

Funding

Agencia Estatal Investigación and European Union, through FEDER (Fondo Europeo de Desarrollo Regional) SAF2016-78756(AEI/FEDER, EU)Generalitat Valenciana (project PROMETEO 2018/024)Ministry of Science, Innovation and Universities of Spain FPU17/00530 Barbara Sanchez-DengraSpanish Government RTI2018-100910-B-C41 and RTI2018-101599-B-C22-AR (MCUI/FEDER, EU)Universitat Politècnica de València-FISABIO (project A41 - METRO-RELEASE)
6 · The paper itself

Abstract

Giardiasis is a parasitism produced by the protozoa

Indexed as

G. intestinalismesoporous microparticlesmolecular gateoral administrationtargeted drug delivery

Identifiers

PMID33451061
PMCPMC7828499
OpenAlexW3119814499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.